SlideShare a Scribd company logo
Molecular Pharmacology
of
Cell Signaling
Mohanad AlBayati
Mohanad AbdulSattar Ali Al-Bayati, BVM&S, MSc. Physiol., PhD.
Assistant Professor of Pharmacology and Toxicology
Department of Physiology and Pharmacology
College of Veterinary Medicine
University of Baghdad
Al Ameria, Baghdad
Phone: 0964 7802120391
E. Mail: aumnmumu@covm.uobaghdad.edu.iq
aumnmumu@yahoo.com
Previous soundness of drug cell
signal
• What is cell signaling?
• Signal transduction
• Receptors
• Types
• Functions
• Steps for signaling
- Guanlyl cyclase activity
Receptors
Receptors are the sites at which biomolecules such as
hormones, neurotransmitters and the molecules responsible
for taste and odour are recognised.
A drug that binds to a receptor can either:
• Trigger the same events as the native ligand - an agonist.
Or
• Stop the binding of the native agent without eliciting a
response - an antagonist.
There are four ‘superfamilies’ of receptors.
. These have 4 or 5 membrane-spanning helical subunits.
Their N- and C-terminii are found in the extracellular fluid. This family
includes ion channels.
. These have 7 helical transmembrane regions. Their N-
terminal is extracellular and the C-terminal in intracellular. This family
is coupled to the action of G-proteins: They are known as the G-
protein coupled receptors.
. These are tyrosine kinase-linked receptors with a single
transmembrane helix. The insulin and growth factor receptors fall
within this family.
. These receptors are found in the cell nucleus and are
transcription factors. They have looped regions held together by a
group of four cysteine residues coordinating to a zinc ion. These motifs
are called zinc fingers. The receptor ligands include steroids and
thyroid hormones.
Receptors
Today soundness of drug cell
signal
 What is G protein coupled receptor
 Regulation
 What is G protein
 Regulation
 Mode of action
G-protein-Coupled Receptors may dimerize or form
oligomeric complexes within the membrane.
Ligand binding may promote oligomerization, which may
in turn affect activity of the receptor.
Various GPCR-interacting proteins (GIPs) modulate
receptor function. Effects of GIPs may include:
 altered ligand affinity
 receptor dimerization or oligomerization
 control of receptor localization, including transfer to
or removal from the plasma membrane
 promoting close association with other signal proteins
Neurotransmitter receptors
Ligand – gated channels:
• Nicotinic acetylcholine receptor
• NMDA-type glutamate receptor
• Glycine receptor
• GABAA receptor
• Serotonin receptor (5-HT3)
G protein-coupled receptors:
• Muscarinic acetylcholine receptor (several types)
• Catecholamine receptors
• Histamine receptors (H1, H2)
• 5-HT receptors other than 5-HT3
• GABAB receptors
• ‘Metabotropic’ glutamate receptors
• Peptide receptors (Endorphin, cholecystokinin..)
`
Into nucleus
Thanks
The G Protein-Coupled Receptor
(GPCR) Superfamily
• Largest known receptor family –
Constitutes > 1% of the genome.
• Comprises receptors for a diverse array of molecules:
neurotransmitters, odorants, lipids, neuropeptides,
large glycoprotein hormones.
• Odorant receptor family alone contains hundreds of
genes.
• Mammalian GPCRs: nearly 300 different kinds –
grouped into 3 main subfamilies:
• Each GPCR family contains some orphan receptors,
which have been identified as members of the GPCR
superfamily by homology cloning but whose
activating ligand is unknown.
• But high throughput screening has recently added to
the advances in being able to identify the ligand.
• GPCRs Interact guanine nucleotide-binding
proteins (aka G-proteins)
• Largest family of membrane proteins in the
human genome
• Eukaryotic trans membrane receptors
• Seven helices spanning the membrane
 Roles:
 - Light and smell processing
- Behavior and mood
- Immune response
- Autonomic nervous system
transmission
- Blood pressure
- Heart rate
- Digestive processes
- CRITICAL FACTOR IN MANY DISEASES!
 Five different classes (based on sequence and
function):
 - Class A: Rhodopsin-like receptors
- Class B: Secretin receptor family
- Class C: Metabotropic
glutamate/pheromone
- Class D: Fungal pheromone receptors
- Class E: Cyclyic AMP receptors
Almost all Receptors Comprise a
Number of Subtypes
• Dopamine receptors - 5 subtypes
• 5-HT receptors – 13 subtypes
• mGlu receptors - 8 subtypes
• Acetylcholine receptors – 5 subtypes
• Identified by their pharmacological and functional
characteristics, rather than by strict sequence
homology:
- Some receptors for the same ligand show
remarkably little homology (e.g., histamine H3
and H4 have the lowest recorded homology (~ 20
%) to other histamine receptors H1 and H2).
Regulation of G protein-coupled
receptor function
Desensitization/resensitization– a decrease in responsiveness
during continuous drug application or a right-shift in a drug
dose-response curve.
After removal of the drug, receptor activity recovers, although
the speed and extent of this resensitization can depend on
the duration of agonist activation.
Rapid desensitization (sec-min) results from receptor phos,
arrestin binding, and receptor internalization.
Long-term desensitization (down-regulation) involve changes in
receptor and/or G protein levels, and their mRNA stability and
expression.
Long-term changes in [GPCR]s and [accessory proteins]s known
to be induced by chronic drug treatment and involved in
several pathologies.
Phosphorylation
2nd messenger kinase
G protein receptor kinase (GRK)
Arrestin
β-arrestin binding to phosphorylated GPCR is
required to decrease GTPase activity prior to
desensitization.
Receptor trafficking, internalization, and
recycling (covered earlier; see Protein
trafficking and LGIC slides).
Mechanisms of long-term down regulation
Long-term (> 1 hr) treatment with agonist induces the loss of total
cellular receptor number in addition to the decr in surface receptor
number.
e.g., antidepressants (e.g., fluoxetine) incr [5HT]synapse decr 5HT
receptor density.
Receptor endocytosis: C-terminal domain determines whether they
enter the recycle pathway or the lysosomal pathway:
- 2 distinct motifs:
1. PDZ-domain interats with NHERF in a phos-dependent manner.
2. A short sequence that interacts with NSF (N-ethylmaleimide
sensitive factor).
Arrestin has also been shown to be important for recycling:
e.g., V2 vasopressin receptor, which continues to bind arrestin while in
endosomes, does not recycle back to plasma membrane.
D D D D
α
α
β
α γ
(1) Agonist binding
and G protein
activation
(2) Phosphorylation
P P
(3) Arrestin
binding
Arrestin
P P
Arrestin
P P
Clathrin(4) Clustering in
clathrin-coated
pits
(5) EndocytosisEndosomes
Arrestin
P P
D
(7) Recycling
(6) Dissociation of agonist:
• Dephosphorylation
• Sorting between cycling
and lysosomal pathways
(8) Traffic to
lysosomes
Lysosomes
Mechanisms of Receptor Regulation
Another Receptor – G Protein Cycle
Structure, function and mechanisms
of G-Proteins
What are G-proteins?
• G proteins bind GTP: guanosine triphosphate. Control and amplify
intracellular signaling pathways
Exist in two states 1) bound GTP: active
2) bound GDP: inactive
Fig. 15.1
Examples of GTPase proteins
Ras, Cdc-42
(hormone, GF, drug)
1994 Nobel Prize in Medicine, Alfred Gilman and
Martin Rodbell, for their „discovery of G-Proteins
and the role of these proteins in signal
transduction in cells.“
G-Protein = Guanine-nucleotide
binding protein
(GNBD)
1
2
5
4
3
Guanine
Ribose
Phosphates
α
1
3
42
6
5 7
89
Guanosine
EsterAnhydride
Guanosine-triphosphate - GTP
G-Protein families
• Heterotrimeric G-Proteins (Transducin, Gi, Gq …), in
7-TM receptor signalling
• Initiation, elongation, termination factors in protein
synthesis (IF1, EF-Tu, EF-TS)
• Signal recognition particle (SRP) and its receptor,
translocation of nascent polypeptide chains in the ER
• Ras-like GTPases (Ras, Rap, Rho, Ran, Rab, Arf, Arl,
Sar), molecular switches in signal transduction
• Dynamin superfamily of GTPases, remodelling of
membranes
+ 60 further distinct families
Leipe et al., JMB (2002)
GTPases and disease.
• Damage to these small GTPase switches can have
catastrophic consequences for the cell and the
organism.
• Several small GTPases of the Rac/Rho subfamily are
direct targets for clostridial cytotoxins.
• Further, Ras proteins are mutated to a constitutively-
active (GTP-bound) form in approximately 20% of
human cancers.
G-proteins are tightly regulated
3 types of accessory proteins that modulate cycling
of G-proteins between GTP/GDP
1. GAPs: GTPase-activating proteins. Stimulate GTP hydrolysis.
Inactivate G-protein. Example of a GAP: PLC.
2. GEFs: Guanine nucleotide-exchange factors: G-protein-coupled
receptors (GPCR). Stimulate dissociation of GDP (inactive) from
G-protein so GTP can bind (active).
3. GDIs: Guanine nucleotide-dissociation inhibitors. Inhibit release
of bound GDP (maintain G-protein in inactive state).
The heterotrimeric G proteins transmit signals
from a variety of cell surface receptors to enzymes
and channels
• Stimulated by receptors
• Act on effectors
• Regulated by nucleotide
exchange and hydrolysis
The signal is usually passed from a 7-helix receptor to an
intracellular G-protein.
 Seven-helix receptors are thus called GPCR, or G-
Protein-Coupled Receptors.
 Approx. 800 different GPCRs are encoded in the human
genome.
 G-proteins are heterotrimeric, with 3 subunits , , .
 A G-protein that activates cyclic-AMP formation within
a cell is called a stimulatory G-protein, designated Gs
with alpha subunit Gs.
 Gs is activated, e.g., by receptors for the hormones
epinephrine and glucagon.
The -adrenergic receptor is the GPCR for
epinephrine.
These domains include residues adjacent to the terminal
phosphate of GTP and/or the Mg++ associated with the
two terminal phosphates.
Inhibitory G
GTPS
PDB 1GIAStructure of G proteins:
The nucleotide binding site
in G consists of loops that
extend out from the edge of
a 6-stranded -sheet.
Three switch domains have
been identified, that change
position when GTP
substitutes for GDP on G.
GTP hydrolysis occurs by nucleophilic attack of a water
molecule on the terminal phosphate of GTP.
Switch domain II of G includes a conserved glutamine
residue that helps to position the attacking water
molecule adjacent to GTP at the active site.
O
OHOH
HH
H
CH2
H
OPOPOP
O
O
O
O
O O
O
NH2
NH
NN
N
O
H O
H
GTP hydrolysis
The  subunit of the heterotrimeric G Protein has a
-propeller structure, formed from multiple repeats of a
sequence called the WD-repeat.
The -propeller provides a stable structural support for
residues that bind G.
It is a common structural motif for protein domains
involved in protein-protein interaction.
G - side view of -propeller
PDB 1GP2
G – face view of -propeller
PDB 1GP2
The family of heterotrimeric G proteins includes also:
 transducin, involved in sensing of light in the retina.
 G-proteins involved in odorant sensing in olfactory
neurons.
There is a larger family of small GTP-binding switch
proteins, related to G.
Small GTP-binding proteins include (roles indicated):
 initiation & elongation factors (protein synthesis).
 Ras (growth factor signal cascades).
 Rab (vesicle targeting and fusion).
 ARF (forming vesicle coatomer coats).
 Ran (transport of proteins into & out of the nucleus).
 Rho (regulation of actin cytoskeleton)
All GTP-binding proteins differ in conformation
depending on whether GDP or GTP is present at their
nucleotide binding site.
Generally, GTP binding induces the active state.
A GAP may provide an essential active site residue, while
promoting the correct positioning of the glutamine
residue of the switch II domain.
Frequently a (+) charged arginine residue of a GAP
inserts into the active site and helps to stabilize the
transition state by interacting with () charged O atoms
of the terminal phosphate of GTP during hydrolysis.
Most GTP-binding
proteins depend on
helper proteins:
GAPs, GTPase Activating
Proteins, promote GTP
hydrolysis.
protein-GTP (active)
GDP
GEF GAP
GTP Pi
protein-GDP (inactive)
 G of a heterotrimeric G protein has innate capability
for GTP hydrolysis.
It has the essential arginine residue normally provided
by a GAP for small GTP-binding proteins.
 However, RGS proteins, which are negative regulators
of G protein signaling, stimulate GTP hydrolysis by G.
protein-GTP (active)
GDP
GEF GAP
GTP Pi
protein-GDP (inactive)
 An activated receptor (GPCR) normally serves as GEF
for a heterotrimeric G-protein.
 Alternatively, AGS (Activator of G-protein Signaling)
proteins may activate some heterotrimeric G-proteins,
independent of a receptor.
Some AGS proteins have GEF activity.
protein-GTP (active)
GDP
GEF GAP
GTP Pi
protein-GDP (inactive)
GEFs, Guanine Nucleotide
Exchange Factors, promote
GDP/GTP exchange.
 &  subunits have covalently attached lipid anchors that
bind a G-protein to the plasma membrane cytosolic surface.
Adenylate Cyclase (AC) is a transmembrane protein, with
cytosolic domains forming the catalytic site.
AC
hormone
signal
outside
GPCR plasma
membrane
GTP GDP ATP cAMP + PPi
 cytosol
GDP GTP
The  subunit of
a G-protein (G)
binds GTP, & can
hydrolyze it to
GDP + Pi.
The sequence of events by which a hormone activates
cAMP signaling:
1. Initially G has bound GDP, and ,, &  subunits
are complexed together.
G,, the complex of  &  subunits, inhibits G.
AC
hormone
signal
outside
GPCR plasma
membrane
GTP GDP ATP cAMP + PPi
 cytosol
GDP GTP
2. Hormone binding, usually to an extracellular domain
of a 7-helix receptor (GPCR), causes a conformational
change in the receptor that is transmitted to a G-protein
on the cytosolic side of the membrane.
The nucleotide-binding site on G becomes more accessible
to the cytosol, where [GTP] > [GDP].
G releases GDP & binds GTP (GDP-GTP exchange).
AC
hormone
signal
outside
GPCR plasma
membrane
GTP GDP ATP cAMP + PPi
 cytosol
GDP GTP
3. Substitution of GTP for GDP causes another
conformational change in G.
G-GTP dissociates from the inhibitory  complex & can
now bind to and activate Adenylate Cyclase.
AC
hormone
signal
outside
GPCR plasma
membrane
GTP GDP ATP cAMP + PPi
 cytosol
GDP GTP
Fig 15.3 The G Protein Cycle
GProtein-LinkedReceptors
GProtein-LinkedReceptors
GProtein-LinkedReceptors
GProtein-LinkedReceptors
note how activation is
reversible
GProtein-LinkedReceptors
the more ligand binding,
the more K+ in cytoplasm
Regulation at the G protein level
Regulator of G protein signaling (RGS = GAPs = GTPase
activating proteins) family of proteins (> 20
members) regulate the rate of GTP hydrolysis in the
Gα subunit.
Can also attenuate G protein actions that are mediated
by βγ subunits, because they can alter the number of
βγ available by enhancing the affinity of Gα subunits
for the βγ after GTP hydrolysis  incr rate of
reformation of the heterotimer.
Regulation at the G protein level (cont’d)
RGS proteins also important in regulating the temporal
characteristics of G protein actions.
E.g., RGS proteins accelerate the decay of agonist-
induced activation of GIRK (G protein regulated
inward rectifying K channels).
E.g., RGS proteins accelerate desensitization of
adrenergic receptor-induced N-type Ca2+ channel
currents.
• ADH - Promotes water retention by
the kidneys (V2 Cells of Posterior Pituitary)
• GHRH - Stimulates the synthesis and release of
GH (Somatotroph Cells of Anterior Pituitary)
• GHIH - Inhibits the synthesis and release of GH
(Somatotroph Cells of Anterior Pituitary)
• CRH - Stimulates the synthesis and release of
ACTH (Anterior Pituitary)
• ACTH - Stimulates the synthesis and release of
Cortisol (zona fasiculata of adrenal cortex in
kidneys)
• TSH - Stimulates the synthesis and release of a
majority of T4 (Thyroid Gland)
• LH - Stimulates follicular maturation and
ovulation in women; Stimulates testosterone
production and spermatogenesis in men
• FSH - Stimulates follicular development in women;
Stimulates spermatogenesis in men
• PTH - Increases blood calcium levels (PTH1 Receptor:
Kidneys and Bone; PTH2 Receptor: Central Nervous
system, Bones, Kidneys, Brain)
• Calcitonin - Decreases blood calcium levels (Calcitonin
Receptor: Intestines, Bones, Kidneys, Brain)
• Glucagon - Stimulates glycogen breakdown (liver)
• hCG - Promotes cellular differentiation; Potentially
involved in apoptosis

How G-protein-coupled receptors work (1)

extracellular space
cytosol
 heterotrimeric
G-protein
‘7TM’ - receptor
GDP
GDP
N
GTP
Ligand
How G-protein-coupled receptors work (2)
inactive

N
GDP

GTP
P

N
active
How G-protein-coupled receptors work (3)
ATP
inactive
inactive
active
cAMP
cAMP
Protein kinase A
Phosphorylation of multiple target proteins
 
GTP
active
Adenylate cyclase
Some G-proteins are inhibitory
-Adrenoceptor
2-Adrenoceptor
s
GTP
AC
active
AC
inactive
i
GTP
-Subunits of G proteins may have
regulatory activity, too
K+
Muscarinic (M2)
acetylcholine receptor
Kir

AC
inactive
i
GTP
G-proteins regulate diverse effector
systems
s
adenylate cyclase  protein kinase AcAMP 
i1
adenylate cyclase  protein kinase AcAMP 
q
phospholipase C 
PIP2 IP3 + DAG protein kinase C
phosphorylation of
multiple proteins
Ca++
ER
t cGMP phosphodiesterase  cGMP 
Many transmitters have multiple GPCR with different
downstream signaling mechanisms
Norepinephrine, 1 IP3 + DAG 
epinephrine2 cAMP 
1,2 cAMP 
Dopamine D2 - D4 cAMP 
D1, D5 cAMP 
Acetylcholine M1,,M4,M5IP3 + DAG 
M2, M3 cAMP 
Thanks

More Related Content

What's hot

Suhas (chronopharmacology of diabetes)
Suhas (chronopharmacology of diabetes)Suhas (chronopharmacology of diabetes)
Suhas (chronopharmacology of diabetes)
suhaspatil114
 
Tyrosine kinase receptors & Nuclear receptors
Tyrosine kinase receptors & Nuclear receptorsTyrosine kinase receptors & Nuclear receptors
Tyrosine kinase receptors & Nuclear receptors
Aaqib Naseer
 
Immunopharmacology
ImmunopharmacologyImmunopharmacology
Immunopharmacology
Jincy13
 
Receptors and receptors classification
Receptors and receptors classificationReceptors and receptors classification
Receptors and receptors classification
caucasus international university
 
Chronopharmacology
ChronopharmacologyChronopharmacology
Chronopharmacology
SameerKhasbage
 
Chronopharmacology
Chronopharmacology Chronopharmacology
Chronopharmacology
Dr. Rupendra Bharti
 
Chronopharmacology
ChronopharmacologyChronopharmacology
Chronopharmacology
ASHUTOSH MISHRA
 
Genetic variation in G protein coupled receptors
Genetic variation in G protein coupled receptorsGenetic variation in G protein coupled receptors
Genetic variation in G protein coupled receptors
SachinGulia12
 
Molecular and cellular mechanism of action of hormones
Molecular and cellular mechanism of action of hormonesMolecular and cellular mechanism of action of hormones
Molecular and cellular mechanism of action of hormones
AbhishekJoshi312
 
General pharmacology 2.1 pharmacodynamics
General pharmacology   2.1 pharmacodynamicsGeneral pharmacology   2.1 pharmacodynamics
General pharmacology 2.1 pharmacodynamics
MangeshBansod2
 
OVERVIEW OF MODERN DRUG DISCOVERY PROCESS
OVERVIEW OF MODERN DRUG DISCOVERY PROCESSOVERVIEW OF MODERN DRUG DISCOVERY PROCESS
OVERVIEW OF MODERN DRUG DISCOVERY PROCESS
Sweety gupta
 
Seminar on histamine
Seminar on histamineSeminar on histamine
Seminar on histamine
kavyakaparthi1
 
Importance of si rna and microrna
Importance of si rna and microrna Importance of si rna and microrna
Importance of si rna and microrna
Deepak Kumar
 
PRINCIPLE AND APPLICATIONS OF CELL VIABILITY, GLUCOSE UPTAKE AND CALCIUM UPT...
PRINCIPLE AND APPLICATIONS OF CELL VIABILITY, GLUCOSE UPTAKE  AND CALCIUM UPT...PRINCIPLE AND APPLICATIONS OF CELL VIABILITY, GLUCOSE UPTAKE  AND CALCIUM UPT...
PRINCIPLE AND APPLICATIONS OF CELL VIABILITY, GLUCOSE UPTAKE AND CALCIUM UPT...
Raghavendra institute of pharmaceutical education and research .
 
screening methods for Antiepileptic activity
screening methods for Antiepileptic activityscreening methods for Antiepileptic activity
screening methods for Antiepileptic activity
Sravanthi Shetty
 
PPT on Cellular and molecular mechanism of sex hormones
PPT on Cellular and molecular mechanism of sex hormonesPPT on Cellular and molecular mechanism of sex hormones
PPT on Cellular and molecular mechanism of sex hormones
Naveen K L
 
Role of genomics proteomics, and bioinformatics.
Role of genomics proteomics, and bioinformatics.Role of genomics proteomics, and bioinformatics.
Role of genomics proteomics, and bioinformatics.
B V V S Hanagal Shri Kumareshwar College of Pharmacy, Bagalkote
 
Non adrenergic non cholinergic transmission(nanc)
Non adrenergic non cholinergic transmission(nanc)Non adrenergic non cholinergic transmission(nanc)
Non adrenergic non cholinergic transmission(nanc)
Merlin Binu
 
RECENT ADVANCES IN ALZHEIMER'S DISEASE
RECENT ADVANCES IN ALZHEIMER'S DISEASERECENT ADVANCES IN ALZHEIMER'S DISEASE
RECENT ADVANCES IN ALZHEIMER'S DISEASE
sharad patange
 
Combinatorial chemistry and high throughput screening
Combinatorial chemistry and high throughput screeningCombinatorial chemistry and high throughput screening
Combinatorial chemistry and high throughput screening
Anji Reddy
 

What's hot (20)

Suhas (chronopharmacology of diabetes)
Suhas (chronopharmacology of diabetes)Suhas (chronopharmacology of diabetes)
Suhas (chronopharmacology of diabetes)
 
Tyrosine kinase receptors & Nuclear receptors
Tyrosine kinase receptors & Nuclear receptorsTyrosine kinase receptors & Nuclear receptors
Tyrosine kinase receptors & Nuclear receptors
 
Immunopharmacology
ImmunopharmacologyImmunopharmacology
Immunopharmacology
 
Receptors and receptors classification
Receptors and receptors classificationReceptors and receptors classification
Receptors and receptors classification
 
Chronopharmacology
ChronopharmacologyChronopharmacology
Chronopharmacology
 
Chronopharmacology
Chronopharmacology Chronopharmacology
Chronopharmacology
 
Chronopharmacology
ChronopharmacologyChronopharmacology
Chronopharmacology
 
Genetic variation in G protein coupled receptors
Genetic variation in G protein coupled receptorsGenetic variation in G protein coupled receptors
Genetic variation in G protein coupled receptors
 
Molecular and cellular mechanism of action of hormones
Molecular and cellular mechanism of action of hormonesMolecular and cellular mechanism of action of hormones
Molecular and cellular mechanism of action of hormones
 
General pharmacology 2.1 pharmacodynamics
General pharmacology   2.1 pharmacodynamicsGeneral pharmacology   2.1 pharmacodynamics
General pharmacology 2.1 pharmacodynamics
 
OVERVIEW OF MODERN DRUG DISCOVERY PROCESS
OVERVIEW OF MODERN DRUG DISCOVERY PROCESSOVERVIEW OF MODERN DRUG DISCOVERY PROCESS
OVERVIEW OF MODERN DRUG DISCOVERY PROCESS
 
Seminar on histamine
Seminar on histamineSeminar on histamine
Seminar on histamine
 
Importance of si rna and microrna
Importance of si rna and microrna Importance of si rna and microrna
Importance of si rna and microrna
 
PRINCIPLE AND APPLICATIONS OF CELL VIABILITY, GLUCOSE UPTAKE AND CALCIUM UPT...
PRINCIPLE AND APPLICATIONS OF CELL VIABILITY, GLUCOSE UPTAKE  AND CALCIUM UPT...PRINCIPLE AND APPLICATIONS OF CELL VIABILITY, GLUCOSE UPTAKE  AND CALCIUM UPT...
PRINCIPLE AND APPLICATIONS OF CELL VIABILITY, GLUCOSE UPTAKE AND CALCIUM UPT...
 
screening methods for Antiepileptic activity
screening methods for Antiepileptic activityscreening methods for Antiepileptic activity
screening methods for Antiepileptic activity
 
PPT on Cellular and molecular mechanism of sex hormones
PPT on Cellular and molecular mechanism of sex hormonesPPT on Cellular and molecular mechanism of sex hormones
PPT on Cellular and molecular mechanism of sex hormones
 
Role of genomics proteomics, and bioinformatics.
Role of genomics proteomics, and bioinformatics.Role of genomics proteomics, and bioinformatics.
Role of genomics proteomics, and bioinformatics.
 
Non adrenergic non cholinergic transmission(nanc)
Non adrenergic non cholinergic transmission(nanc)Non adrenergic non cholinergic transmission(nanc)
Non adrenergic non cholinergic transmission(nanc)
 
RECENT ADVANCES IN ALZHEIMER'S DISEASE
RECENT ADVANCES IN ALZHEIMER'S DISEASERECENT ADVANCES IN ALZHEIMER'S DISEASE
RECENT ADVANCES IN ALZHEIMER'S DISEASE
 
Combinatorial chemistry and high throughput screening
Combinatorial chemistry and high throughput screeningCombinatorial chemistry and high throughput screening
Combinatorial chemistry and high throughput screening
 

Similar to Molecular pharmacology of cell signling

Cell signalling 2
Cell signalling   2Cell signalling   2
Cell signalling 2
Dr. Khuram Aziz
 
Receptors-1
Receptors-1Receptors-1
Receptors-1
Samrul Islam
 
Receptors 1
Receptors 1Receptors 1
Receptors 1
Sayeed Samrul
 
Basic concepts of G – protein coupled receptor.pptx
Basic concepts of G – protein coupled receptor.pptxBasic concepts of G – protein coupled receptor.pptx
Basic concepts of G – protein coupled receptor.pptx
ssuser1c7442
 
G protein–coupled receptor
G protein–coupled receptorG protein–coupled receptor
G protein–coupled receptor
Harsha Chowdary
 
G- Protein Coupled Receptors
G- Protein Coupled ReceptorsG- Protein Coupled Receptors
G- Protein Coupled Receptors
Dr. Prashant Shukla
 
Gpcr genetic variation
Gpcr genetic variationGpcr genetic variation
Gpcr genetic variation
Sreenivasa Reddy Thalla
 
26426-F22-Wk 2 Lecture - Receptors (2).pdf
26426-F22-Wk 2 Lecture - Receptors (2).pdf26426-F22-Wk 2 Lecture - Receptors (2).pdf
26426-F22-Wk 2 Lecture - Receptors (2).pdf
safuraqazi
 
G protein coupled receptor
G protein coupled receptorG protein coupled receptor
G protein coupled receptor
Sumit Kumar
 
G protein coupled receptor
G protein coupled receptorG protein coupled receptor
G protein coupled receptor
Sumit Kumar
 
gproteincoupledreceptor-170520064151 2.pdf
gproteincoupledreceptor-170520064151 2.pdfgproteincoupledreceptor-170520064151 2.pdf
gproteincoupledreceptor-170520064151 2.pdf
bajosalimatou9
 
genetic variation in gpcr and its disease due to variation
genetic variation in gpcr and its disease due to variationgenetic variation in gpcr and its disease due to variation
genetic variation in gpcr and its disease due to variation
NittalVekaria
 
Genetics variations in gpcr
Genetics variations in gpcrGenetics variations in gpcr
Genetics variations in gpcr
Deepak Kumar
 
TYPES OF RECEPTORS
TYPES OF RECEPTORS TYPES OF RECEPTORS
TYPES OF RECEPTORS
Bhavesh Amrute
 
13-miller-chap-15-lecture (2).ppt1234578
13-miller-chap-15-lecture (2).ppt123457813-miller-chap-15-lecture (2).ppt1234578
13-miller-chap-15-lecture (2).ppt1234578
alizain9604
 
13-miller-chap-15-lecture (1).ppt23457834
13-miller-chap-15-lecture (1).ppt2345783413-miller-chap-15-lecture (1).ppt23457834
13-miller-chap-15-lecture (1).ppt23457834
alizain9604
 
13-miller-chap-15-lecture.ppt
13-miller-chap-15-lecture.ppt13-miller-chap-15-lecture.ppt
13-miller-chap-15-lecture.ppt
anshikabhatnagar1299
 
13-miller-chap-15-lecture.ppt1234578900000000000000009875444333333333333333332
13-miller-chap-15-lecture.ppt123457890000000000000000987544433333333333333333213-miller-chap-15-lecture.ppt1234578900000000000000009875444333333333333333332
13-miller-chap-15-lecture.ppt1234578900000000000000009875444333333333333333332
alizain9604
 
Cell Receptors
Cell ReceptorsCell Receptors
Cell Receptors
Ashish Chari
 
Cell signalling -
Cell signalling  -Cell signalling  -
Cell signalling -
aqeel hadithe
 

Similar to Molecular pharmacology of cell signling (20)

Cell signalling 2
Cell signalling   2Cell signalling   2
Cell signalling 2
 
Receptors-1
Receptors-1Receptors-1
Receptors-1
 
Receptors 1
Receptors 1Receptors 1
Receptors 1
 
Basic concepts of G – protein coupled receptor.pptx
Basic concepts of G – protein coupled receptor.pptxBasic concepts of G – protein coupled receptor.pptx
Basic concepts of G – protein coupled receptor.pptx
 
G protein–coupled receptor
G protein–coupled receptorG protein–coupled receptor
G protein–coupled receptor
 
G- Protein Coupled Receptors
G- Protein Coupled ReceptorsG- Protein Coupled Receptors
G- Protein Coupled Receptors
 
Gpcr genetic variation
Gpcr genetic variationGpcr genetic variation
Gpcr genetic variation
 
26426-F22-Wk 2 Lecture - Receptors (2).pdf
26426-F22-Wk 2 Lecture - Receptors (2).pdf26426-F22-Wk 2 Lecture - Receptors (2).pdf
26426-F22-Wk 2 Lecture - Receptors (2).pdf
 
G protein coupled receptor
G protein coupled receptorG protein coupled receptor
G protein coupled receptor
 
G protein coupled receptor
G protein coupled receptorG protein coupled receptor
G protein coupled receptor
 
gproteincoupledreceptor-170520064151 2.pdf
gproteincoupledreceptor-170520064151 2.pdfgproteincoupledreceptor-170520064151 2.pdf
gproteincoupledreceptor-170520064151 2.pdf
 
genetic variation in gpcr and its disease due to variation
genetic variation in gpcr and its disease due to variationgenetic variation in gpcr and its disease due to variation
genetic variation in gpcr and its disease due to variation
 
Genetics variations in gpcr
Genetics variations in gpcrGenetics variations in gpcr
Genetics variations in gpcr
 
TYPES OF RECEPTORS
TYPES OF RECEPTORS TYPES OF RECEPTORS
TYPES OF RECEPTORS
 
13-miller-chap-15-lecture (2).ppt1234578
13-miller-chap-15-lecture (2).ppt123457813-miller-chap-15-lecture (2).ppt1234578
13-miller-chap-15-lecture (2).ppt1234578
 
13-miller-chap-15-lecture (1).ppt23457834
13-miller-chap-15-lecture (1).ppt2345783413-miller-chap-15-lecture (1).ppt23457834
13-miller-chap-15-lecture (1).ppt23457834
 
13-miller-chap-15-lecture.ppt
13-miller-chap-15-lecture.ppt13-miller-chap-15-lecture.ppt
13-miller-chap-15-lecture.ppt
 
13-miller-chap-15-lecture.ppt1234578900000000000000009875444333333333333333332
13-miller-chap-15-lecture.ppt123457890000000000000000987544433333333333333333213-miller-chap-15-lecture.ppt1234578900000000000000009875444333333333333333332
13-miller-chap-15-lecture.ppt1234578900000000000000009875444333333333333333332
 
Cell Receptors
Cell ReceptorsCell Receptors
Cell Receptors
 
Cell signalling -
Cell signalling  -Cell signalling  -
Cell signalling -
 

More from Mohanad Al-Bayati

Drugs acting on the central nervous system
Drugs acting on the central nervous systemDrugs acting on the central nervous system
Drugs acting on the central nervous system
Mohanad Al-Bayati
 
CV
CVCV
Pharmacogenetic
Pharmacogenetic Pharmacogenetic
Pharmacogenetic
Mohanad Al-Bayati
 
Nanopharmacology
Nanopharmacology Nanopharmacology
Nanopharmacology
Mohanad Al-Bayati
 
Msc pharmacology hormonal
Msc pharmacology  hormonalMsc pharmacology  hormonal
Msc pharmacology hormonal
Mohanad Al-Bayati
 
Endothelium derived factors
Endothelium derived factorsEndothelium derived factors
Endothelium derived factors
Mohanad Al-Bayati
 
Clinical pharmacology hormonal disorders
Clinical pharmacology hormonal disordersClinical pharmacology hormonal disorders
Clinical pharmacology hormonal disorders
Mohanad Al-Bayati
 
Pharmacology of hypothermia
Pharmacology of hypothermia Pharmacology of hypothermia
Pharmacology of hypothermia
Mohanad Al-Bayati
 
Control of the of analytical methods
Control of the of analytical methodsControl of the of analytical methods
Control of the of analytical methods
Mohanad Al-Bayati
 

More from Mohanad Al-Bayati (9)

Drugs acting on the central nervous system
Drugs acting on the central nervous systemDrugs acting on the central nervous system
Drugs acting on the central nervous system
 
CV
CVCV
CV
 
Pharmacogenetic
Pharmacogenetic Pharmacogenetic
Pharmacogenetic
 
Nanopharmacology
Nanopharmacology Nanopharmacology
Nanopharmacology
 
Msc pharmacology hormonal
Msc pharmacology  hormonalMsc pharmacology  hormonal
Msc pharmacology hormonal
 
Endothelium derived factors
Endothelium derived factorsEndothelium derived factors
Endothelium derived factors
 
Clinical pharmacology hormonal disorders
Clinical pharmacology hormonal disordersClinical pharmacology hormonal disorders
Clinical pharmacology hormonal disorders
 
Pharmacology of hypothermia
Pharmacology of hypothermia Pharmacology of hypothermia
Pharmacology of hypothermia
 
Control of the of analytical methods
Control of the of analytical methodsControl of the of analytical methods
Control of the of analytical methods
 

Recently uploaded

Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
chandankumarsmartiso
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Swastik Ayurveda
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
Swastik Ayurveda
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
bkling
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
chandankumarsmartiso
 

Recently uploaded (20)

Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
 

Molecular pharmacology of cell signling

  • 1. Molecular Pharmacology of Cell Signaling Mohanad AlBayati Mohanad AbdulSattar Ali Al-Bayati, BVM&S, MSc. Physiol., PhD. Assistant Professor of Pharmacology and Toxicology Department of Physiology and Pharmacology College of Veterinary Medicine University of Baghdad Al Ameria, Baghdad Phone: 0964 7802120391 E. Mail: aumnmumu@covm.uobaghdad.edu.iq aumnmumu@yahoo.com
  • 2. Previous soundness of drug cell signal • What is cell signaling? • Signal transduction • Receptors • Types • Functions • Steps for signaling
  • 3.
  • 4.
  • 5. - Guanlyl cyclase activity
  • 6.
  • 7. Receptors Receptors are the sites at which biomolecules such as hormones, neurotransmitters and the molecules responsible for taste and odour are recognised. A drug that binds to a receptor can either: • Trigger the same events as the native ligand - an agonist. Or • Stop the binding of the native agent without eliciting a response - an antagonist. There are four ‘superfamilies’ of receptors.
  • 8. . These have 4 or 5 membrane-spanning helical subunits. Their N- and C-terminii are found in the extracellular fluid. This family includes ion channels. . These have 7 helical transmembrane regions. Their N- terminal is extracellular and the C-terminal in intracellular. This family is coupled to the action of G-proteins: They are known as the G- protein coupled receptors. . These are tyrosine kinase-linked receptors with a single transmembrane helix. The insulin and growth factor receptors fall within this family. . These receptors are found in the cell nucleus and are transcription factors. They have looped regions held together by a group of four cysteine residues coordinating to a zinc ion. These motifs are called zinc fingers. The receptor ligands include steroids and thyroid hormones. Receptors
  • 9. Today soundness of drug cell signal  What is G protein coupled receptor  Regulation  What is G protein  Regulation  Mode of action
  • 10.
  • 11.
  • 12. G-protein-Coupled Receptors may dimerize or form oligomeric complexes within the membrane. Ligand binding may promote oligomerization, which may in turn affect activity of the receptor. Various GPCR-interacting proteins (GIPs) modulate receptor function. Effects of GIPs may include:  altered ligand affinity  receptor dimerization or oligomerization  control of receptor localization, including transfer to or removal from the plasma membrane  promoting close association with other signal proteins
  • 13. Neurotransmitter receptors Ligand – gated channels: • Nicotinic acetylcholine receptor • NMDA-type glutamate receptor • Glycine receptor • GABAA receptor • Serotonin receptor (5-HT3) G protein-coupled receptors: • Muscarinic acetylcholine receptor (several types) • Catecholamine receptors • Histamine receptors (H1, H2) • 5-HT receptors other than 5-HT3 • GABAB receptors • ‘Metabotropic’ glutamate receptors • Peptide receptors (Endorphin, cholecystokinin..)
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23. `
  • 24.
  • 25.
  • 26.
  • 27.
  • 28.
  • 29.
  • 30.
  • 31.
  • 32.
  • 33.
  • 34.
  • 35.
  • 36.
  • 37.
  • 38.
  • 39.
  • 40.
  • 41.
  • 42.
  • 44.
  • 45.
  • 47. The G Protein-Coupled Receptor (GPCR) Superfamily • Largest known receptor family – Constitutes > 1% of the genome. • Comprises receptors for a diverse array of molecules: neurotransmitters, odorants, lipids, neuropeptides, large glycoprotein hormones. • Odorant receptor family alone contains hundreds of genes. • Mammalian GPCRs: nearly 300 different kinds – grouped into 3 main subfamilies:
  • 48. • Each GPCR family contains some orphan receptors, which have been identified as members of the GPCR superfamily by homology cloning but whose activating ligand is unknown. • But high throughput screening has recently added to the advances in being able to identify the ligand.
  • 49. • GPCRs Interact guanine nucleotide-binding proteins (aka G-proteins) • Largest family of membrane proteins in the human genome • Eukaryotic trans membrane receptors • Seven helices spanning the membrane
  • 50.  Roles:  - Light and smell processing - Behavior and mood - Immune response - Autonomic nervous system transmission - Blood pressure - Heart rate - Digestive processes - CRITICAL FACTOR IN MANY DISEASES!
  • 51.  Five different classes (based on sequence and function):  - Class A: Rhodopsin-like receptors - Class B: Secretin receptor family - Class C: Metabotropic glutamate/pheromone - Class D: Fungal pheromone receptors - Class E: Cyclyic AMP receptors
  • 52. Almost all Receptors Comprise a Number of Subtypes • Dopamine receptors - 5 subtypes • 5-HT receptors – 13 subtypes • mGlu receptors - 8 subtypes • Acetylcholine receptors – 5 subtypes • Identified by their pharmacological and functional characteristics, rather than by strict sequence homology: - Some receptors for the same ligand show remarkably little homology (e.g., histamine H3 and H4 have the lowest recorded homology (~ 20 %) to other histamine receptors H1 and H2).
  • 53.
  • 54. Regulation of G protein-coupled receptor function Desensitization/resensitization– a decrease in responsiveness during continuous drug application or a right-shift in a drug dose-response curve. After removal of the drug, receptor activity recovers, although the speed and extent of this resensitization can depend on the duration of agonist activation. Rapid desensitization (sec-min) results from receptor phos, arrestin binding, and receptor internalization. Long-term desensitization (down-regulation) involve changes in receptor and/or G protein levels, and their mRNA stability and expression. Long-term changes in [GPCR]s and [accessory proteins]s known to be induced by chronic drug treatment and involved in several pathologies.
  • 55. Phosphorylation 2nd messenger kinase G protein receptor kinase (GRK) Arrestin β-arrestin binding to phosphorylated GPCR is required to decrease GTPase activity prior to desensitization. Receptor trafficking, internalization, and recycling (covered earlier; see Protein trafficking and LGIC slides).
  • 56. Mechanisms of long-term down regulation Long-term (> 1 hr) treatment with agonist induces the loss of total cellular receptor number in addition to the decr in surface receptor number. e.g., antidepressants (e.g., fluoxetine) incr [5HT]synapse decr 5HT receptor density. Receptor endocytosis: C-terminal domain determines whether they enter the recycle pathway or the lysosomal pathway: - 2 distinct motifs: 1. PDZ-domain interats with NHERF in a phos-dependent manner. 2. A short sequence that interacts with NSF (N-ethylmaleimide sensitive factor). Arrestin has also been shown to be important for recycling: e.g., V2 vasopressin receptor, which continues to bind arrestin while in endosomes, does not recycle back to plasma membrane.
  • 57. D D D D α α β α γ (1) Agonist binding and G protein activation (2) Phosphorylation P P (3) Arrestin binding Arrestin P P Arrestin P P Clathrin(4) Clustering in clathrin-coated pits (5) EndocytosisEndosomes Arrestin P P D (7) Recycling (6) Dissociation of agonist: • Dephosphorylation • Sorting between cycling and lysosomal pathways (8) Traffic to lysosomes Lysosomes Mechanisms of Receptor Regulation
  • 58. Another Receptor – G Protein Cycle
  • 59. Structure, function and mechanisms of G-Proteins
  • 60. What are G-proteins? • G proteins bind GTP: guanosine triphosphate. Control and amplify intracellular signaling pathways Exist in two states 1) bound GTP: active 2) bound GDP: inactive Fig. 15.1 Examples of GTPase proteins Ras, Cdc-42 (hormone, GF, drug)
  • 61. 1994 Nobel Prize in Medicine, Alfred Gilman and Martin Rodbell, for their „discovery of G-Proteins and the role of these proteins in signal transduction in cells.“
  • 62. G-Protein = Guanine-nucleotide binding protein (GNBD) 1 2 5 4 3 Guanine Ribose Phosphates α 1 3 42 6 5 7 89 Guanosine EsterAnhydride Guanosine-triphosphate - GTP
  • 63. G-Protein families • Heterotrimeric G-Proteins (Transducin, Gi, Gq …), in 7-TM receptor signalling • Initiation, elongation, termination factors in protein synthesis (IF1, EF-Tu, EF-TS) • Signal recognition particle (SRP) and its receptor, translocation of nascent polypeptide chains in the ER • Ras-like GTPases (Ras, Rap, Rho, Ran, Rab, Arf, Arl, Sar), molecular switches in signal transduction • Dynamin superfamily of GTPases, remodelling of membranes + 60 further distinct families Leipe et al., JMB (2002)
  • 64. GTPases and disease. • Damage to these small GTPase switches can have catastrophic consequences for the cell and the organism. • Several small GTPases of the Rac/Rho subfamily are direct targets for clostridial cytotoxins. • Further, Ras proteins are mutated to a constitutively- active (GTP-bound) form in approximately 20% of human cancers.
  • 65. G-proteins are tightly regulated 3 types of accessory proteins that modulate cycling of G-proteins between GTP/GDP 1. GAPs: GTPase-activating proteins. Stimulate GTP hydrolysis. Inactivate G-protein. Example of a GAP: PLC. 2. GEFs: Guanine nucleotide-exchange factors: G-protein-coupled receptors (GPCR). Stimulate dissociation of GDP (inactive) from G-protein so GTP can bind (active). 3. GDIs: Guanine nucleotide-dissociation inhibitors. Inhibit release of bound GDP (maintain G-protein in inactive state).
  • 66. The heterotrimeric G proteins transmit signals from a variety of cell surface receptors to enzymes and channels • Stimulated by receptors • Act on effectors • Regulated by nucleotide exchange and hydrolysis
  • 67. The signal is usually passed from a 7-helix receptor to an intracellular G-protein.  Seven-helix receptors are thus called GPCR, or G- Protein-Coupled Receptors.  Approx. 800 different GPCRs are encoded in the human genome.
  • 68.  G-proteins are heterotrimeric, with 3 subunits , , .  A G-protein that activates cyclic-AMP formation within a cell is called a stimulatory G-protein, designated Gs with alpha subunit Gs.  Gs is activated, e.g., by receptors for the hormones epinephrine and glucagon. The -adrenergic receptor is the GPCR for epinephrine.
  • 69. These domains include residues adjacent to the terminal phosphate of GTP and/or the Mg++ associated with the two terminal phosphates. Inhibitory G GTPS PDB 1GIAStructure of G proteins: The nucleotide binding site in G consists of loops that extend out from the edge of a 6-stranded -sheet. Three switch domains have been identified, that change position when GTP substitutes for GDP on G.
  • 70. GTP hydrolysis occurs by nucleophilic attack of a water molecule on the terminal phosphate of GTP. Switch domain II of G includes a conserved glutamine residue that helps to position the attacking water molecule adjacent to GTP at the active site. O OHOH HH H CH2 H OPOPOP O O O O O O O NH2 NH NN N O H O H GTP hydrolysis
  • 71. The  subunit of the heterotrimeric G Protein has a -propeller structure, formed from multiple repeats of a sequence called the WD-repeat. The -propeller provides a stable structural support for residues that bind G. It is a common structural motif for protein domains involved in protein-protein interaction. G - side view of -propeller PDB 1GP2 G – face view of -propeller PDB 1GP2
  • 72. The family of heterotrimeric G proteins includes also:  transducin, involved in sensing of light in the retina.  G-proteins involved in odorant sensing in olfactory neurons. There is a larger family of small GTP-binding switch proteins, related to G.
  • 73. Small GTP-binding proteins include (roles indicated):  initiation & elongation factors (protein synthesis).  Ras (growth factor signal cascades).  Rab (vesicle targeting and fusion).  ARF (forming vesicle coatomer coats).  Ran (transport of proteins into & out of the nucleus).  Rho (regulation of actin cytoskeleton) All GTP-binding proteins differ in conformation depending on whether GDP or GTP is present at their nucleotide binding site. Generally, GTP binding induces the active state.
  • 74. A GAP may provide an essential active site residue, while promoting the correct positioning of the glutamine residue of the switch II domain. Frequently a (+) charged arginine residue of a GAP inserts into the active site and helps to stabilize the transition state by interacting with () charged O atoms of the terminal phosphate of GTP during hydrolysis. Most GTP-binding proteins depend on helper proteins: GAPs, GTPase Activating Proteins, promote GTP hydrolysis. protein-GTP (active) GDP GEF GAP GTP Pi protein-GDP (inactive)
  • 75.  G of a heterotrimeric G protein has innate capability for GTP hydrolysis. It has the essential arginine residue normally provided by a GAP for small GTP-binding proteins.  However, RGS proteins, which are negative regulators of G protein signaling, stimulate GTP hydrolysis by G. protein-GTP (active) GDP GEF GAP GTP Pi protein-GDP (inactive)
  • 76.  An activated receptor (GPCR) normally serves as GEF for a heterotrimeric G-protein.  Alternatively, AGS (Activator of G-protein Signaling) proteins may activate some heterotrimeric G-proteins, independent of a receptor. Some AGS proteins have GEF activity. protein-GTP (active) GDP GEF GAP GTP Pi protein-GDP (inactive) GEFs, Guanine Nucleotide Exchange Factors, promote GDP/GTP exchange.
  • 77.  &  subunits have covalently attached lipid anchors that bind a G-protein to the plasma membrane cytosolic surface. Adenylate Cyclase (AC) is a transmembrane protein, with cytosolic domains forming the catalytic site. AC hormone signal outside GPCR plasma membrane GTP GDP ATP cAMP + PPi  cytosol GDP GTP The  subunit of a G-protein (G) binds GTP, & can hydrolyze it to GDP + Pi.
  • 78.
  • 79. The sequence of events by which a hormone activates cAMP signaling: 1. Initially G has bound GDP, and ,, &  subunits are complexed together. G,, the complex of  &  subunits, inhibits G. AC hormone signal outside GPCR plasma membrane GTP GDP ATP cAMP + PPi  cytosol GDP GTP
  • 80. 2. Hormone binding, usually to an extracellular domain of a 7-helix receptor (GPCR), causes a conformational change in the receptor that is transmitted to a G-protein on the cytosolic side of the membrane. The nucleotide-binding site on G becomes more accessible to the cytosol, where [GTP] > [GDP]. G releases GDP & binds GTP (GDP-GTP exchange). AC hormone signal outside GPCR plasma membrane GTP GDP ATP cAMP + PPi  cytosol GDP GTP
  • 81. 3. Substitution of GTP for GDP causes another conformational change in G. G-GTP dissociates from the inhibitory  complex & can now bind to and activate Adenylate Cyclase. AC hormone signal outside GPCR plasma membrane GTP GDP ATP cAMP + PPi  cytosol GDP GTP
  • 82. Fig 15.3 The G Protein Cycle
  • 87. GProtein-LinkedReceptors the more ligand binding, the more K+ in cytoplasm
  • 88. Regulation at the G protein level Regulator of G protein signaling (RGS = GAPs = GTPase activating proteins) family of proteins (> 20 members) regulate the rate of GTP hydrolysis in the Gα subunit. Can also attenuate G protein actions that are mediated by βγ subunits, because they can alter the number of βγ available by enhancing the affinity of Gα subunits for the βγ after GTP hydrolysis  incr rate of reformation of the heterotimer.
  • 89. Regulation at the G protein level (cont’d) RGS proteins also important in regulating the temporal characteristics of G protein actions. E.g., RGS proteins accelerate the decay of agonist- induced activation of GIRK (G protein regulated inward rectifying K channels). E.g., RGS proteins accelerate desensitization of adrenergic receptor-induced N-type Ca2+ channel currents.
  • 90. • ADH - Promotes water retention by the kidneys (V2 Cells of Posterior Pituitary) • GHRH - Stimulates the synthesis and release of GH (Somatotroph Cells of Anterior Pituitary) • GHIH - Inhibits the synthesis and release of GH (Somatotroph Cells of Anterior Pituitary) • CRH - Stimulates the synthesis and release of ACTH (Anterior Pituitary)
  • 91. • ACTH - Stimulates the synthesis and release of Cortisol (zona fasiculata of adrenal cortex in kidneys) • TSH - Stimulates the synthesis and release of a majority of T4 (Thyroid Gland) • LH - Stimulates follicular maturation and ovulation in women; Stimulates testosterone production and spermatogenesis in men
  • 92. • FSH - Stimulates follicular development in women; Stimulates spermatogenesis in men • PTH - Increases blood calcium levels (PTH1 Receptor: Kidneys and Bone; PTH2 Receptor: Central Nervous system, Bones, Kidneys, Brain) • Calcitonin - Decreases blood calcium levels (Calcitonin Receptor: Intestines, Bones, Kidneys, Brain) • Glucagon - Stimulates glycogen breakdown (liver) • hCG - Promotes cellular differentiation; Potentially involved in apoptosis
  • 93.  How G-protein-coupled receptors work (1)  extracellular space cytosol  heterotrimeric G-protein ‘7TM’ - receptor GDP GDP N GTP Ligand
  • 94. How G-protein-coupled receptors work (2) inactive  N GDP  GTP P  N active
  • 95. How G-protein-coupled receptors work (3) ATP inactive inactive active cAMP cAMP Protein kinase A Phosphorylation of multiple target proteins   GTP active Adenylate cyclase
  • 96. Some G-proteins are inhibitory -Adrenoceptor 2-Adrenoceptor s GTP AC active AC inactive i GTP
  • 97. -Subunits of G proteins may have regulatory activity, too K+ Muscarinic (M2) acetylcholine receptor Kir  AC inactive i GTP
  • 98. G-proteins regulate diverse effector systems s adenylate cyclase  protein kinase AcAMP  i1 adenylate cyclase  protein kinase AcAMP  q phospholipase C  PIP2 IP3 + DAG protein kinase C phosphorylation of multiple proteins Ca++ ER t cGMP phosphodiesterase  cGMP 
  • 99. Many transmitters have multiple GPCR with different downstream signaling mechanisms Norepinephrine, 1 IP3 + DAG  epinephrine2 cAMP  1,2 cAMP  Dopamine D2 - D4 cAMP  D1, D5 cAMP  Acetylcholine M1,,M4,M5IP3 + DAG  M2, M3 cAMP 
  • 100. Thanks